MT-3921

· Tanabe Pharma America, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MT-3921, covering 2025-12-16 to 2025-12-16. Get the full timeline:

Most recent: Clinical Trial Update: Study to Assess the Efficacy and Safety of MT-3921 in Subjects With Acute Traumatic Cervical Spinal Cord Injury [Phase 2]

See pricing